Short-term effects of severe hypoglycaemia in children and adolescents with type 1 diabetes. A cost-of-illness study

2007 ◽  
Vol 90 (2) ◽  
pp. 137-142 ◽  
Author(s):  
S Nordfeldt ◽  
D Jonsson
Keyword(s):  
Type 1 Diabetes ◽  
Children And Adolescents ◽  
Cost Of Illness ◽  
Severe Hypoglycaemia ◽  
Short Term ◽  
Illness Study ◽  
Cost Of Illness Study ◽  
Short Term Effects

Treatment costs of prostate cancer in the first year after diagnosis: a short-term cost of illness study for France, Germany, Italy, Spain and the UK

2010 ◽  
Vol 105 (1) ◽  
pp. 49-56 ◽  
Author(s):  
Richard Olivier Fourcade ◽  
ÁGnes Benedict ◽  
Libby K. Black ◽  
Michael E. Stokes ◽  
Antonio Alcaraz ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cost Of Illness ◽  
Treatment Costs ◽  
First Year ◽  
Short Term ◽  
Illness Study ◽  
The Uk ◽  
Cost Of Illness Study

scholarly journals Short-term effects of coping skills training in school-age children with type 1 diabetes

2008 ◽  
Vol 9 (3pt2) ◽  
pp. 74-82 ◽  
Author(s):  
Jodie M Ambrosino ◽  
Kristopher Fennie ◽  
Robin Whittemore ◽  
Sarah Jaser ◽  
Michael F Dowd ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Coping Skills ◽  
Skills Training ◽  
School Age Children ◽  
School Age ◽  
Short Term ◽  
Coping Skills Training ◽  
Short Term Effects

scholarly journals Losing Track of Lipids in Children and Adolescents with Type 1 Diabetes: Towards Individualized Patient Care

2019 ◽  
Author(s):  
Josine C. van der Heyden ◽  
Erwin Birnie ◽  
Sarah A. Bovenberg ◽  
Pim Dekker ◽  
Henk J. Veeze ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
High Risk ◽  
Children And Adolescents ◽  
Risk Score ◽  
Low Risk ◽  
Diabetes Duration ◽  
Lipid Levels ◽  
Short Term ◽  
The Impact

Abstract Aim To assess 1) the prevalence of children and adolescents with type 1 diabetes (T1D) changing from low-risk into borderline-high-risk lipid levels or from borderline-high-risk into high-risk lipid levels (‘lose track of lipids’) and 2) the power of a risk score including the determinants HbA1c, body mass index (BMI), gender, age, diabetes duration and ethnicity in predicting which patients lose track of lipids. Methods 651 children and adolescents with T1D were included in this longitudinal retrospective cohort study. Lipid dynamics and the impact of the risk score on losing track of lipids were evaluated. Kaplan-Meier analysis was used to estimate screening intervals. Results 31–43% percent of the patients had lost track of one or more lipids at the next lipid measurement. This happened more frequently in patients with a low-risk lipid level at start. Depending on the lipid parameter, 5% of patients with low-risk lipid levels lost track of lipids after 13–23 months. The risk score based on concomitant information on the determinants was moderately able to predict which patients would lose track of lipids on the short term. Conclusions A considerable number of children and adolescents with T1D loses track of lipids and does so within a 2-year screening interval. The predictive power of a risk score including age, BMI, gender, HbA1c, diabetes duration and ethnicity is only moderate. Future research should focus on another approach to the determinants used in this study or other determinants predictive of losing track of lipids on the short term.

Short-term metabolic control and sleep in children and adolescents with type 1 diabetes mellitus

2018 ◽  
Vol 32 (6) ◽  
pp. 580-585 ◽  
Author(s):  
Martina Kostkova ◽  
Peter Durdik ◽  
Miriam Ciljakova ◽  
Jarmila Vojtkova ◽  
Anna Sujanska ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 1 Diabetes ◽  
Type 1 Diabetes Mellitus ◽  
Children And Adolescents ◽  
Metabolic Control ◽  
Short Term

scholarly journals The relationship between ACE genotype and risk of severe hypoglycaemia in a large population-based cohort of children and adolescents with type 1 diabetes

Diabetologia ◽  
2007 ◽  
Vol 50 (5) ◽  
pp. 965-971 ◽  
Author(s):  
M. K. Bulsara ◽  
C. D. J. Holman ◽  
F. M. van Bockxmeer ◽  
E. A. Davis ◽  
P. H. Gallego ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Children And Adolescents ◽  
Severe Hypoglycaemia ◽  
Large Population ◽  
Population Based ◽  
Ace Genotype ◽  
The Relationship

scholarly journals Glycaemic control and prevalence of hypoglycaemic events in children and adolescents with type 1 diabetes mellitus treated with insulin analogues

2014 ◽  
Vol 71 (9) ◽  
pp. 817-820 ◽  
Author(s):  
Ljiljana Plavsic ◽  
Katarina Mitrovic ◽  
Sladjana Todorovic ◽  
Rade Vukovic ◽  
Tatjana Milenkovic ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 1 Diabetes ◽  
Glycaemic Control ◽  
Children And Adolescents ◽  
Severe Hypoglycaemia ◽  
Insulin Analogues ◽  
Group I ◽  
Group Ii ◽  
Long Acting

Background/Aim. An ideal insulin regimen for children and adolescents with type 1 diabetes mellitus (T1DM) should be physiological, flexibile and predictable, protecting against hypoglycaemia. The aim of this study was to evaluate the influence of insulin analogues on glycaemic control and the occurrence of hypoglycaemic episodes in children and adolescents with T1DM. Methods. The study group consisted of 151 children and adolescents (90 boys, 61 girls) treated with human insulins for at least 12 months before introducing insulin analogues. All the patients were divided into two groups: the group I consisted of 72 (47.7%) patients treated with three injections of regular human insulin before meals and long-acting analogue (RHI/LA), and the group II of 79 (52.3%) patients treated with a combination of rapid-acting and long-acting analogue (RA/LA). The levels of glycated hemoglobin (HbA1c) and the number of hypoglycaemic episodes were assessed at the beginning of therapy with insulin analogues, and after 6 and 12 months. Results. The mean HbA1c was significantly lower in the group I (RHI/LA) after 6 months (9.15% vs 8.20%, p < 0.001) and after 12 months (9.15% vs 8.13%, p < 0.001) as well as in the group II (RA/LA) after 6 months (9.40% vs 8.24%, p < 0.001) and after 12 months of insulin analogues treatment (9.40% vs 8.38%, p < 0.001). The frequency of severe hypoglycaemia was significantly lower in both groups after 6 months (in the group I from 61.1% to 4.2% and in the group II from 54.4% to 1.3%, p < 0.001), and after 12 months (in the group I from 61.1% to 1.4% and in the group II from 54.4% to 1.3%, p < 0.001). Conclusion. Significantly better HbA1c values and lower risk of severe hypoglycaemia were established in children and adolescents with T1DM treated with insulin analogues.

Sign in / Sign up

Export Citation Format

Share Document